The event will bring together C-Suite executives from leading public and private companies from around the globe and across diverse healthcare sub-sectors. In 2024, we hosted over 700 healthcare companies, 3,600 attendees, and 10,000 investor and business-to-business meetings. New for 2025, Monday, November 17 will mark the launch of a focused Biotech/Biopharma Kick-off Day, while […]
The Advanced Therapies Congress is America's most exciting cell and gene therapy conference and exhibition. The event is designed for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. The conference brings together a community of 1,200 global executives […]
RESI London and Gensis are combining to offer a multi-day investment, partnering and thought leadership event for venture stage companies seeking funding and strategic alliances.
Join us for the 67th ASH Annual Meeting and Exposition, taking place December 6–9, 2025, in Orlando, Florida, and online — the world’s leading event uniting experts and innovators shaping the future of hematology.
Antibody Engineering is Experiencing Unprecedented Innovation. Are You Leading or Following? This event is a strategic investment for your R&D teams to fast-track antibodies from discovery to the clinic and beyond by applying cutting-edge innovation across AI, computational breakthroughs and beyond.
Join us at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium, which offers the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care.
The RESI Conference will be held on January 12-13 at the San Francisco Marriott Marquis, featuring two days in-person event followed by three days (January 14, 19&20) of online partnership activities. Previous RESI JPM conferences have drawn over a thousand attendees, including more than 500 early-stage life science investors, innovators, and industry experts. This RESI […]
San Francisco, CA
Leading investor conference that connects private and micro-mid-cap biotech companies with investors and biopharma executives, providing a platform to showcase their innovations and facilitate one-on-one meetings.
BIO One-on-One Partnering unifies access to partnering for the life science industry. You can efficiently arrange meetings with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders, regardless of whether you are registered for a specific event during JPM Week.
This premier conference is the largest and most informative healthcare investment symposium in the industry, which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
The pharma and biotech industries stand at an inflection point unseen since the genomic revolution. After years of pandemic-fueled growth and subsequent market turmoil, companies are redefining how they will survive and thrive. Capital is scarcer. Regulators worldwide are rewriting the rules. Breakthrough therapies in oncology, rare diseases and obesity are upending competition, even as […]
